Comment on Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors
Am J Gastroenterol
.
2020 Nov;115(11):1921.
doi: 10.14309/ajg.0000000000001014.
Authors
Homer Boushey
1
,
Igor Gonda
2
Affiliations
1
Emeritus Professor of Medicine, UCSF, San Francisco, California, USA.
2
Respidex LLC, Dennis, Massachusetts, USA.
PMID:
33156117
DOI:
10.14309/ajg.0000000000001014
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
Proton Pump Inhibitors* / adverse effects
Risk Factors
SARS-CoV-2
Substances
Proton Pump Inhibitors